Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 18163-47-8 Chemical Structure| 18163-47-8

Structure of 18163-47-8

Chemical Structure| 18163-47-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 18163-47-8 ]

CAS No. :18163-47-8
Formula : C5H9ISi
M.W : 224.11
SMILES Code : C[Si](C#CI)(C)C
MDL No. :MFCD00274201
InChI Key :HNIRHTRSZDSMOF-UHFFFAOYSA-N
Pubchem ID :140341

Safety of [ 18163-47-8 ]

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H225-H302-H312-H317-H332
Precautionary Statements:P280
Class:3
UN#:1993
Packing Group:

Computational Chemistry of [ 18163-47-8 ] Show Less

Physicochemical Properties

Num. heavy atoms 7
Num. arom. heavy atoms 0
Fraction Csp3 0.6
Num. rotatable bonds 0
Num. H-bond acceptors 0.0
Num. H-bond donors 0.0
Molar Refractivity 45.14
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

0.0 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.07
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

3.14
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.34
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

2.81
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.63
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.2

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-3.21
Solubility 0.139 mg/ml ; 0.00062 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.81
Solubility 0.347 mg/ml ; 0.00155 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.19
Solubility 1.46 mg/ml ; 0.00652 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

Low
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.44 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

3.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

4.06

Application In Synthesis of [ 18163-47-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 18163-47-8 ]

[ 18163-47-8 ] Synthesis Path-Downstream   1~35

  • 1
  • [ 18163-47-8 ]
  • [ 3220-49-3 ]
  • [ 2170-06-1 ]
  • 2
  • [ 18163-47-8 ]
  • [ 54248-47-4 ]
  • [ 56904-79-1 ]
  • 3
  • [ 18163-47-8 ]
  • [ 4526-07-2 ]
  • 4
  • [ 598-25-4 ]
  • [ 18163-47-8 ]
  • [ 78389-99-8 ]
  • 5
  • [ 463-49-0 ]
  • [ 18163-47-8 ]
  • [ 78389-95-4 ]
  • 6
  • [ 628-71-7 ]
  • [ 18163-47-8 ]
  • [ 70600-64-5 ]
  • 7
  • [ 26981-77-1 ]
  • [ 18163-47-8 ]
  • (6,6-Dimethyl-hepta-3,4-dien-1-ynyl)-trimethyl-silane [ No CAS ]
  • 8
  • [ 18163-47-8 ]
  • [ 433-06-7 ]
  • [ 123455-96-9 ]
  • 1,1-difluoro-2-(4-phenylbutyl)-4-trimethylsilyl-1-buten-3-yne [ No CAS ]
  • 9
  • [ 18163-47-8 ]
  • 6-Tributylstannyl-2',3'-isopropylidene-5'-O-methoxymethyluridine [ No CAS ]
  • [ 105967-15-5 ]
  • 10
  • [ 18163-47-8 ]
  • [ 153432-70-3 ]
  • 1-<<2-(trimethylsilyl)ethoxy>methyl>-2-<2-(trimethylsilyl)ethynyl>-1H-indole [ No CAS ]
YieldReaction ConditionsOperation in experiment
bis-triphenylphosphine-palladium(II) chloride; In tetrahydrofuran; at 65℃; for 3.5h;Heating / reflux; A 2-neck, 500 ML flask equipped with a reflux condenser and dropping funnel was charged with Pd(PPh3)2Cl2 (748.1 mg, 98%, 1.0 mmol) under a positive pressure of dry nitrogen.Dry THF (200 ML was added by cannula, followed by 1-iodo-2-(trimethylsilyl)acetylene (10.98 g, 48.99 mmol).The reaction was heated to reflux by a preheated oil bath and stannane 3 in 55 ML of dry THF was added dropwise over 2.5 h.The reaction was monitored by TLC, and was complete 1 h after the addition of stannane was complete.The reaction was cooled to room temperature, diluted with EtOAc (750 ML), stirred over 15% KF (aq) (750 ML) for 15 min and filtered through paper.The organic layer was isolated and the aqueous layer extracted with Et2O (3*300 ML).The combined organics were washed with water (500 ML) and brine (500 ML), dried (Na2SO4), filtered and reduced to a dark oil to give crude 4.The crude material was dissolved in IPrOH (75 ML) and 1 M NaOH (aq) (75 ML) and stirred at rt.The reaction was complete within 30 min.The reaction was poured into water (400 ML) and extracted with Et2O (3*400 ML).The combined organics were washed with water (400 ML) and brine (400 ML), Dried (Na2SO4), filtered and reduced to oil.The residue was purified by flash column chromatography (petroleum ether/Et2O 9:1 eluant) afforded 9.00 g of 5 (88%, two steps) as a colorless oil.Analytical TLC indicated a single compound (10% Et2O in petroleum ether eluant, Rf=0.48). Data for 5: 1H NMR (500 MHz, CDCl3, delta): -0.06 (s, 9H), 0.88-0.91 (m, 2H), 3.50 (s, 1H), 3.53-3.56 (m, 2H), 5.64 (s, 2H), 6.86 (s,1H), 7.15-7.18 (m,1H), 7.28-7.31 (m,1H), 7.48 (dd, J=8.3, 0.5 Hz, 1H), 7.57-7.60 (m, 1H). 13C NMR (75 MHz, CDCl3, delta): -1.49, 17.69, 65.74, 73.02, 75.33, 83.75, 109.93, 110.43, 120.62, 120.98, 121.07, 123.82, 127.29, 136.86. IR (film): 3305.0, 2952.5, 2894.6, 2107.9, 1452.7, 1390.0, 1334.9, 1312.6, 1248.7, 1162.4, 1115.0, 1091.6, 1076.7, 930.2, 900.2, 859.4, 835.7, 794.0, 747.7, 692.5 cm-1. HRMS (m/z): [M+] calcd for C16H21NOSi, 271.1392; found, 271.1385.
  • 11
  • [ 18163-47-8 ]
  • [ 168335-78-2 ]
  • [ 882005-06-3 ]
  • 13
  • [ 18163-47-8 ]
  • [ 2873-29-2 ]
  • [ 115029-76-0 ]
  • 1-(4,6-di-O-acetyl-2,3-dideoxy-D-erythro-hex-2-enopyranosyl)-2-trimethylsilylacetylene [ No CAS ]
  • 14
  • [ 934561-63-4 ]
  • [ 18163-47-8 ]
  • [ 934561-66-7 ]
  • 15
  • [ 18163-47-8 ]
  • [ 882005-26-7 ]
  • 16
  • [ 18163-47-8 ]
  • [ 882005-23-4 ]
  • 17
  • [ 18163-47-8 ]
  • [ 882005-24-5 ]
  • 18
  • [ 18163-47-8 ]
  • [ 882005-25-6 ]
  • 19
  • [ 18163-47-8 ]
  • (2E,4Z,6R)-1-tert-butyldimethylsilyloxy-4-ethyl-6-methyl-9-trimethylsilanyl-2,4-nonadien-8-yne [ No CAS ]
  • 20
  • [ 18163-47-8 ]
  • [ 153432-94-1 ]
  • 21
  • C40H56N2O11 [ No CAS ]
  • [ 18163-47-8 ]
  • [ 1098594-17-2 ]
YieldReaction ConditionsOperation in experiment
With copper(l) iodide; triethylamine;bis-triphenylphosphine-palladium(II) chloride; In acetonitrile; at 20℃; for 14h; A solution of Example 1A (15 g, 0.02 mol) in acetonitrile (150 mL) and triethylamine (75 mL) at room temperature was treated with dichlorobis(triphenylphosphine)palladium(II) (0.994 g, 1.4 mmol), copper(I) iodide (0.115 g, 0.6 mmol), and 1-iodo-2-(trimethylsilyl)acetylene (5.9 mL, 0.0385 mol), stirred at room temperature for 14 hours, and concentrated. The concentrate was suspended in ether and filtered through diatomaceous earth (Celite). The filtrate was washed with water and brine, dried (Na2SO4), filtered, and concentrated. The concentrate was purified by flash column chromatography on silica gel with 85:15 hexanes/acetone to provide the desired product.
  • 22
  • [ 18163-47-8 ]
  • [ 2720-03-8 ]
  • [ 200009-43-4 ]
YieldReaction ConditionsOperation in experiment
75% With n-butyllithium; In tetrahydrofuran; hexane; EXAMPLE 3 [(dipentafluorophenylboryl)ethynyl]trimethylsilane 1.12 g (5 mmol) of (iodoethynyl)trimethylsilane are dissolved in 40 ml of tetrahydrofuran and cooled to -78 C. 3.2 ml of n-BuLi (5 mmol, 1.6M in hexane) are slowly added dropwise to this solution and the mixture is stirred for 2 hours. Subsequently, 1.90 g (5 mmol) of bis(pentafluorophenyl)boryl chloride are dissolved in 40 ml of tetrahydrofuran and likewise added dropwise to the above solution. The resulting suspension is slowly warmed to room temperature, forming a white precipitant. This is separated off by filtration. The solvent is removed from the filtrate obtained under reduced pressure. The remaining yellow oil is subsequently fractionally distilled. This gives 1.66 g (75% yield) of [(dipentafluorophenylboryl)ethynyl]trimethylsilane.
  • 23
  • [ 18163-47-8 ]
  • [ 107-19-7 ]
  • [ 56053-89-5 ]
YieldReaction ConditionsOperation in experiment
83% With bis-triphenylphosphine-palladium(II) chloride; copper(l) iodide; diisopropylamine; In tetrahydrofuran; at 20℃; for 4h;Inert atmosphere; A solution of diisopropylamine (3.82 mL, 26.8 mmol), CuI (34.0 mg, 0.178 mmol), and Pd(PPh3)2Cl2 (46.8 mg, 0.178 mmol) in anhydrous THF (50 mL) was degassed with argon before 1-iodo-2-(trimethylsilyl)acetylene 9 (2.00 g, 8.92 mmol) and propargyl alcohol (0.619 mL, 10.7 mL) were added. The mixture was stirred at room temperature for 4 h. The brown reaction mixture was filtered through a plug of Celite, washing with EtOAc. The filtrate was concentrated in vacuo to give a brown residue. The crude material was purified by silica gel chromatography (gradient: 0-20% EtOAc in cyclohexane) to afford title compound 10 (1.36 g, 83% yield) as a brown oil. 1H NMR data obtained were consistent with those reported in literature.10 Rf=0.50 (20% EtOAc/cyclohexane); 1H NMR (400 MHz, CDCl3) delta=4.33 (d, J=6.0 Hz, 2H), 1.57 (t, J=6.4 Hz, 1H), 0.20 (s, 9H); IR numax(film) 3350, 2959, 2899, 2108, 1250, 1018, 843, 760 cm-1.
With diisopropylamine;bis-triphenylphosphine-palladium(II) chloride; copper(l) iodide; complex 2 was prepared via the synthetic route given in FIGURE 2
  • 24
  • ferrocenylcopper [ No CAS ]
  • [ 18163-47-8 ]
  • 1-ferrocenyl-2-trymethylsilylacetylene [ No CAS ]
  • 25
  • 1,1'-dicopperferrocene*dimethylsulphide [ No CAS ]
  • [ 18163-47-8 ]
  • 1,1’-bis(trimethylsilylethynyl)ferrocene [ No CAS ]
  • 26
  • [ 14221-01-3 ]
  • [ 18163-47-8 ]
  • [ 136892-76-7 ]
  • 27
  • [ 55332-53-1 ]
  • [ 18163-47-8 ]
  • [ 136862-76-5 ]
  • 28
  • [ 28069-69-4 ]
  • [ 18163-47-8 ]
  • tetrakis(trimethylphosphine){(trimethylsilyl)ethynyl}nickel(II) iodide [ No CAS ]
  • 29
  • [ 101077-61-6 ]
  • [ 18163-47-8 ]
  • NiI(P(CH3)3)2(C(CCSi(CH3)3)C(Si(CH3)3)(CCSi(CH3)3)) [ No CAS ]
  • 30
  • (η(5)-C5Me5)Re(PPh3)(NO)(C.tplbond.CC.tplbond.CH) [ No CAS ]
  • [ 18163-47-8 ]
  • [ 228997-59-9 ]
  • 31
  • (η5-C5H4Si(CH3)3)2Ti(CCSi(CH3)3)2CuCH3 [ No CAS ]
  • [ 18163-47-8 ]
  • [(η(5)-C5H4SiMe3)2Ti(C.tplbond.CSiMe3)2]CuI [ No CAS ]
  • 32
  • Re(CO)3(CH3)2C10H6N2C3CH [ No CAS ]
  • [ 18163-47-8 ]
  • Re(CO)3((CH3)2C10H6N2)C5CSi(CH3)3*0.5C4H8O [ No CAS ]
  • 33
  • Re(CO)3((C4H9)2C10H6N2)C3CH [ No CAS ]
  • [ 18163-47-8 ]
  • Re(CO)3((C4H9)2C10H6N2)C5CSi(CH3)3*0.5C4H8O [ No CAS ]
  • 34
  • (η5-C5H4Si(CH3)3)2Ti(CCC(CH3)3)2CuCCSi(CH3)3 [ No CAS ]
  • [ 18163-47-8 ]
  • ((C5H4Si(CH3)3)2Ti(CCC(CH3)3)2)CuI [ No CAS ]
  • 35
  • (η5-C5H4Si(CH3)3)2Ti(CCC(CH3)3)2CuCH3 [ No CAS ]
  • [ 18163-47-8 ]
  • ((C5H4Si(CH3)3)2Ti(CCC(CH3)3)2)CuI [ No CAS ]
 

Historical Records

Technical Information

Categories